SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 29, 1997
(December 24, 1997)
LASERSIGHT INCORPORATED
-----------------------
Exact name of registrant as specified in its charter
Delaware
--------
State or other jurisdiction of incorporation
0-19671 65-0273162
------- ----------
Commission File Number I.R.S. Employer
Identification No.
12161 Lackland Road, St. Louis, Missouri 63146
----------------------------------------------
Address of Principal Executive Offices
Registrant's telephone number, including area code: (314) 469-3220
<PAGE>
Item 5. Other Events.
The press release issued by LaserSight Incorporated dated December 24, 1997 is
incorporated by reference herein.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
Exhibit 99. Press Release dated December 24, 1997
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LaserSight Incorporated
Date: December 29, 1997 By: /s/ Michael R. Farris
-----------------------------
Michael R. Farris
Chief Executive Officer
EXHIBIT 99
NASDAQ SYMBOL: LASE
AGREEMENT WITH PREFERRED SHAREHOLDERS
OBTAINED BY LASERSIGHT INCORPORATED
ST. LOUIS, MO (Dec. 24, 1997) -- Holders of LaserSight Incorporated's (NASDAQ:
LASE) Series B Preferred Stock agreed to extend the date by which the company is
required to obtain the approval of its common shareholders of the conversion and
other terms of the preferred stock. The extension runs from an original date of
Dec. 26, 1997, through a new date of Feb. 28, 1998.
LaserSight had issued the Series B Preferred Stock in August 1997 to finance its
acquisition from International Business Machines Corporation (NYSE: IBM) of all
of IBM's rights under several patents relating to Ultraviolet Light Ophthalmic
products and procedures. LaserSight also acquired from IBM all of its rights
under its patent license agreements with VISX, Inc. and Summit Technology, Inc.
The special shareholders' meeting regarding approval of this matter was
previously scheduled for Dec. 10, 1997. The meeting will enable the company's
common shareholders to vote on approving the terms of the Series B Preferred
Stock and whether to increase the number of authorized shares of common stock.
To date, none of the shares of the Series B Preferred Stock have been converted
into common stock.
LaserSight officials expect to soon announce a new date for this shareholders'
meeting, subject to the completion of a review of the company's preliminary
proxy material by the Securities and Exchange Commission staff.
This press release contains forward-looking statements regarding future events
and future performance of the company, which involve risks and uncertainties
that could materially affect actual results. Investors should refer to documents
that the company files from time-to-time with the Securities and Exchange
Commission for a description of certain factors that could cause actual results
to vary from current expectations and the forward-looking statements contained
in this press release. Such filings include, without limitation, the company's
Form 10-K, Form 10-Q and Form 8-K reports.
# # #
For additional information please contact: Julie Tockman
Director, Corporate Relations
LaserSight Incorporated
(314) 469-3220
Visit us on the Internet at www.lase.
com
